PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer (Q44235056)

1 December 2017

title

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer (English)

1 reference

1 December 2017

J Li

1

1 reference

1 December 2017

Z Yang

2

1 reference

1 December 2017

Q Zou

3

1 reference

1 December 2017

Y Yuan

4

1 reference

1 December 2017

J Li

5

1 reference

1 December 2017

L Liang

6

1 reference

1 December 2017

G Zeng

7

1 reference

1 December 2017

S Chen

8

1 reference

1 December 2017

publication date

21 June 2013

1 reference

Clinical and Translational Oncology

1 December 2017

published in

1 reference

1 December 2017

volume

16

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

200-207

1 reference

Management of gallbladder cancer

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Pyruvate kinase type M2 and its role in tumor growth and spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Activin Receptor-Like Kinase and the Insulin Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Identification of PEG10 and TSG101 as Carcinogenesis, Progression, and Poor-Prognosis Related Biomarkers for Gallbladder Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12094-013-1063-8

Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer

21 January 2018

1 reference

12 December 2020

Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours

1 reference

12 December 2020

Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder

1 reference

12 December 2020

Cyclosporine A inhibits breast cancer cell growth by downregulating the expression of pyruvate kinase subtype M2

1 reference

12 December 2020

Adenosquamous carcinoma of the gallbladder

1 reference

12 December 2020

10.1007/S12094-013-1063-8

Identifiers

DOI

1 reference

1 December 2017

1 reference